Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2020-11-13

Ulipristal acetate for uterine fibroids: EMA recommends restricting use

View source ↗

Summary

EMA recommends restricting the use of ulipristal acetate for uterine fibroids due to safety concerns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ulipristal acetate (ulipristal acetate)